Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.1510
-0.0141
(-8.54%)
At close: April 2 at 3:38:30 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Paul Y. Song M.D. | CEO & Chairman | 650k | -- | 1966 |
| Dr. Yong Man Kim Ph.D. | Chief Scientific Officer | 60k | -- | 1965 |
| Mr. James A. Graf | Interim Chief Financial Officer | -- | -- | 1965 |
| Ms. Yoonmi Kang | SVP of Technical Ops & Development | -- | -- | -- |
| Ms. Irene Chang | SVP, HR & Corporate Culture | -- | -- | -- |
| Ms. Denise A. Chua CLS, MBA, MT (ASCP) | SVP of Corporate Affairs | -- | -- | -- |
| Mr. Ryan Park C.F.A. | EVP of Financial Planning & Analysis and Corporate Strategy | -- | -- | -- |
NKGen Biotech, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 63
Description
NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. Its lead products include SNK01, an autologous NK cell therapy candidate treatment for neurodegenerative diseases; and SNK02, an allogeneic NK cell therapy, which is in Phase 1 clinical trials for refractory solid tumors. The company has a license agreement with NKMAX. The company was formerly known as NKMAX America, Inc. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California.
Corporate Governance
NKGen Biotech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 14, 2025 at 8:00 PM UTC - April 18, 2025 at 8:00 PM UTC
NKGen Biotech, Inc. Earnings Date
Recent Events
Related Tickers
TVGN Tevogen Bio Holdings Inc.
1.0700
-1.83%
SPRC SciSparc Ltd.
0.3040
+5.96%
ZVSA ZyVersa Therapeutics, Inc.
0.5873
-0.03%
PXMD PaxMedica, Inc.
0.0002
0.00%
LIXT Lixte Biotechnology Holdings, Inc.
1.2200
+2.52%
BDRX Biodexa Pharmaceuticals Plc
1.5400
+28.33%
ATXI Avenue Therapeutics, Inc.
0.2621
-12.63%
NLSP NLS Pharmaceutics AG
1.4900
-2.61%
MRSN Mersana Therapeutics, Inc.
0.3399
+1.68%
ERNA Ernexa Therapeutics Inc.
0.1910
+3.30%